| Literature DB >> 25838870 |
Christos Rammos1, Matthias Totzeck1, René Deenen2, Karl Köhrer2, Malte Kelm3, Tienush Rassaf1, Ulrike B Hendgen-Cotta1.
Abstract
Aging leads to a number of disadvantageous changes in the cardiovascular system. Deterioration of vascular homoeostasis with increase in oxidative stress, chronic low-grade inflammation, and impaired nitric oxide bioavailability results in endothelial dysfunction, increased vascular stiffness, and compromised arterial-ventricular interactions. A chronic dietary supplementation with the micronutrient nitrate has been demonstrated to improve vascular function. Healthy dietary patterns may regulate gene expression profiles. However, the mechanisms are incompletely understood. The changes that occur at the gene expression level and transcriptional profile following a nutritional modification with nitrate have not been elucidated. To determine the changes of the vascular transcriptome, we conducted gene expression microarray experiments on aortas of old mice, which were treated with dietary nitrate. Our results highlight differentially expressed genes overrepresented in gene ontology categories. Molecular interaction and reaction pathways involved in the calcium-signaling pathway and the detoxification system were identified. Our results provide novel insight to an altered gene-expression profile in old mice following nitrate supplementation. This supports the general notion of nutritional approaches to modulate age-related changes of vascular functions and its detrimental consequences.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25838870 PMCID: PMC4369962 DOI: 10.1155/2015/658264
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Age-related endothelial dysfunction is reversed by dietary nitrate supplementation. (a) and (b) endothelium dependent function determined by dose-responses and maximum vasodilation to the endothelium-dependent dilator acetylcholine (ACh) in young, old, and nitrite-supplemented old male mice (YC, OC and ON). (c) Dose-responses to the endothelium-independent vasodilator sodium nitroprusside (SNP). (Values are mean ± SEM, n = 6, * P < 0.05.)
Figure 2Differentially expressed transcripts in old male C57BL/6 aortas following nitrate treatment (n = 6; determined from total 26,774 transcripts; fold change > 1.2; P < 0.05). Old control versus old nitrate yielded 1565 upregulated and 1335 downregulated transcripts.
Dietary nitrate induced enriched gene ontology terms in old mice. Enriched gene ontology (GO) terms according to biological processes, molecular functions and cellular components. GO terms are ordered by Fisher exact test (i.e., ease score) with highest enriched term at the top of the list. FDR, false discovery rate.
| Term | Count | % |
| FDR |
|---|---|---|---|---|
| Biological process | ||||
| Brown fat cell differentiation | 15 | 0.7 | 1.3 | 2.4 |
| Rhythmic process | 19 | 0.9 | 1.4 | 2.4 |
| Extracellular structure organization | 30 | 1.5 | 2.1 | 3.7 |
| Negative regulation of lipid metabolic process | 6 | 0.3 | 2.3 | 4.1 |
| Signal transduction | 209 | 10.2 | 4.0 | 7.0 |
| Response to hormone stimulus | 29 | 1.4 | 4.2 | 7.3 |
| Fat cell differentiation | 17 | 0.8 | 6.1 | 1.1 |
| Regulation of cell proliferation | 77 | 3.7 | 6.9 | 1.2 |
| Negative regulation of multicellular organismal process | 19 | 0.9 | 9.7 | 1.6 |
| System development | 226 | 11.0 | 1.3 | 2.1 |
| Response to endogenous stimulus | 29 | 1.4 | 1.3 | 2.1 |
| Extracellular matrix organization | 20 | 1.0 | 1.4 | 2.3 |
| Response to hypoxia | 15 | 0.7 | 1.7 | 2.7 |
|
| ||||
| Cellular compartment | ||||
| Membrane | 703 | 34.2 | 6.1 | 8.8 |
| Integral to membrane | 492 | 24.0 | 9.8 | 1.4 |
| Extracellular region part | 98 | 4.8 | 1.0 | 1.5 |
| Extracellular region | 169 | 8.2 | 1.8 | 2.6 |
| Membrane part | 634 | 30.9 | 1.9 | 2.8 |
| Intrinsic to membrane | 507 | 24.7 | 3.6 | 5.2 |
| Extracellular matrix | 50 | 2.4 | 9.3 | 1.3 |
| Proteinaceous extracellular matrix | 48 | 2.3 | 1.0 | 1.5 |
| Extracellular matrix part | 22 | 1.1 | 3.9 | 5.6 |
| Basement membrane | 18 | 0.9 | 1.4 | 2.0 |
| Mitochondrial inner membrane | 56 | 2.7 | 2.0 | 2.8 |
| Plasma membrane | 291 | 14.2 | 4.8 | 6.6 |
| Mitochondrion | 190 | 9.3 | 6.1 | 8.4 |
|
| ||||
| Molecular function | ||||
| Antigen binding | 14 | 0.7 | 7.1 | 1.1 |
| Transmembrane receptor activity | 88 | 4.3 | 1.6 | 2.6 |
| Molecular transducer activity | 172 | 8.4 | 6.1 | 9.3 |
| Signal transducer activity | 172 | 8.4 | 6.1 | 9.3 |
| Protein tyrosine kinase activity | 28 | 1.4 | 9.9 | 1.5 |
| cAMP-dependent protein kinase regulator activity | 5 | 0.2 | 1.0 | 1.5 |
| Receptor activity | 142 | 6.9 | 1.1 | 1.6 |
| Oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 9 | 0.4 | 1.5 | 2.2 |
| Kinase regulator activity | 16 | 0.8 | 1.9 | 2.7 |
| Cation transmembrane transporter activity | 57 | 2.8 | 2.0 | 2.8 |
| Copper ion binding | 13 | 0.6 | 2.1 | 2.9 |
| Oxidoreductase activity | 10 | 0.5 | 2.6 | 3.4 |
| Potassium ion binding | 16 | 0.8 | 2.9 | 3.8 |
Figure 3Enriched pathways in aortas of old nitrate treated male mice. Highest enriched KEGG, Panther, and Biocarta pathways are displayed of old aortic tissue following nitrate supplementation. Individual pathways and corresponding gene count are sorted by negative log [P value].
Differentially expressed genes related to calcium pathway in old versus old nitrate treated mice.
| Gene symbol | Description | Regulation | Fold change |
|
|---|---|---|---|---|
| Atp2a1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Up | 1.2 | 0.010 |
| Atp2b2 | ATPase, Ca++ transporting, plasma membrane 2 | Up | 1.3 | 0.018 |
| Ptk2b | PTK2 protein tyrosine kinase 2 beta | Down | 1.2 | 0.008 |
| Adcy7 | Adenylate cyclase 7 | Up | 1.4 | 0.001 |
| Adra1a | Adrenergic receptor, alpha 1a | Down | 1.5 | 0.002 |
| Adrb3 | Adrenergic receptor, beta 3 | Down | 1.9 | 0.004 |
| Cacna1d | Calcium channel, voltage-dependent, L type, alpha 1D subunit | Up | 1.4 | 0.013 |
| Ppapdc2 | Calcium channel, voltage-dependent, L type, alpha 1S subunit | Down | 1.3 | 0.010 |
| Camk4 | Calcium/calmodulin-dependent protein kinase IV | Up | 1.4 | 0.009 |
| F2r | Coagulation factor II (thrombin) receptor | Up | 1.3 | 0.001 |
| Ednrb | Endothelin receptor type B | Down | 1.2 | 0.045 |
| Gna14 | Guanine nucleotide binding protein, alpha 14 | Up | 1.6 | 0.031 |
| Itpr2 | Inositol 1,4,5-triphosphate receptor 2 | Down | 1.3 | 0.001 |
| Itpr3 | Inositol 1,4,5-triphosphate receptor 3 | Up | 1.2 | 0.024 |
| Itpka | Inositol 1,4,5-trisphosphate 3-kinase A | Down | 1.4 | 0.017 |
| Nos2 | Nitric oxide synthase 2, inducible | Down | 1.2 | 0.019 |
| Oxtr | Oxytocin receptor | Down | 1.4 | 0.042 |
| Plcb4 | Phospholipase C, beta 4 | Up | 1.4 | 0.005 |
| Plcd1 | Phospholipase C, delta 1 | Up | 1.2 | 0.001 |
| Phka2 | Phosphorylase kinase alpha 2 | Down | 1.2 | 0.037 |
| Pdgfrb | Platelet derived growth factor receptor, beta polypeptide | Up | 1.2 | 0.007 |
| Calm2 | Calmodulin 2 | Up | 1.2 | 0.020 |
| Ptger1 | Prostaglandin E receptor 1 (subtype EP1) | Up | 1.2 | 0.023 |
| Ptger3 | Prostaglandin E receptor 3 (subtype EP3) | Down | 1.9 | 0.020 |
| Prkx | Protein kinase, X-linked | Down | 1.2 | 0.031 |
| Ppp3cc | Protein phosphatase 3, catalytic subunit, gamma isoform | Down | 1.3 | 0.025 |
| P2rx3 | Purinergic receptor P2X, ligand-gated ion channel, 3 | Up | 1.3 | 0.035 |
| Ryr2 | Ryanodine receptor 2, cardiac | Up | 1.4 | 0.007 |
| Camk2g | Similar to Calcium/calmodulin-dependent protein kinase type II gamma chain | Up | 1.3 | 0.010 |
| Sphk2 | Sphingosine kinase 2 | Down | 1.2 | 0.021 |
Figure 4Calcium signaling pathway in old nitrate treated aorta. KEGG-pathway analysis determined by DAVID Bioinformatics resources showing differentially expressed genes highlighted with red stars (for up-/downregulation refer to Table 2).
Enriched genes associated with the biological process of detoxification, antioxidation, and free radical removal, according to Panther Gene Ontology in old versus old nitrate treated mice.
| Gene symbol | Description | Regulation | Fold change |
|
|---|---|---|---|---|
| pAbcc1 | ATP-binding cassette, subfamily C (CFTR/MRP), member 1 | Up | 1.2 | 0.007 |
| Asna1 | arsA arsenite transporter, ATP-binding | Down | 1.2 | 0.025 |
| Ces1d | Carboxyl esterase 3 | Down | 1.4 | 0.002 |
| Ces1f | Expressed sequence AU018778 | Down | 1.6 | 0.010 |
| Ephx1 | Epoxide hydrolase 1, microsomal | Up | 1.3 | 0.015 |
| Gpx3 | Glutathione peroxidase 3 | Down | 1.5 | 0.001 |
| Gpx4 | Heterogeneous nuclear ribonucleoprotein L-like; glutathione peroxidase 4 | Down | 1.4 | 0.003 |
| Gsta3 | Glutathione S-transferase, alpha 3 | Down | 2.1 | 0.039 |
| Gsta4 | Glutathione S-transferase, alpha 4 | Down | 1.5 | 0.010 |
| Gstm4 | Glutathione S-transferase, mu 4 | Down | 1.3 | 0.009 |
| Gstt3 | Glutathione S-transferase, theta 3 | Up | 1.2 | 0.020 |
| Gstz1 | Glutathione transferase zeta 1 | Down | 1.3 | 0.034 |
| Haghl | Hydroxyacyl glutathione hydrolase-like | Up | 1.2 | 0.006 |
| Mgst1 | Microsomal glutathione S-transferase 1 | Down | 1.3 | 0.044 |
| Mgst2 | Microsomal glutathione S-transferase 2 | Down | 1.7 | 0.015 |
| Mgst3 | Microsomal glutathione S-transferase 3 | Down | 1.2 | 0.044 |
| Mpv17l | Mpv17 transgene, kidney disease mutant-like | Up | 1.3 | 0.001 |
| Nos2 | Nitric oxide synthase 2, inducible | Down | 1.2 | 0.019 |
| Pnkd | Paroxysmal nonkinesiogenic dyskinesia | Down | 1.4 | 0.030 |
| Pon3 | Paraoxonase 3 | Down | 1.2 | 0.002 |
| Prdx4 | Peroxiredoxin 4 | Up | 1.2 | 0.001 |
| Prdx5 | Peroxiredoxin 5 | Down | 1.2 | 0.011 |
| Pxmp2 | Peroxisomal membrane protein 2 | Down | 1.2 | 0.011 |
| Sod1 | Superoxide dismutase 1, soluble | Down | 1.2 | 0.015 |
| Sod3 | Superoxide dismutase 3, extracellular | Up | 1.2 | 0.015 |
| Tst | Thiosulfate sulfotransferase, mitochondrial | Down | 1.3 | 0.037 |
| Txndc16 | Thioredoxin domain containing 16 | Up | 1.2 | 0.009 |
| Txnl4a | Thioredoxin-like 4A | Down | 1.2 | 0.002 |